150 related articles for article (PubMed ID: 7309251)
1. Toxic metabolites from biotransformation: major organ damage.
Van Dyke RA
Int Anesthesiol Clin; 1981; 19(4):39-67. PubMed ID: 7309251
[No Abstract] [Full Text] [Related]
2. Effect of enzyme induction on nephrotoxicity of halothane-related compounds.
Hitt BA; Mazze RI
Environ Health Perspect; 1977 Dec; 21():179-83. PubMed ID: 612443
[TBL] [Abstract][Full Text] [Related]
3. Role of biotransformation in the toxicity of inhalation anesthetics.
Vaughan RW; Sipes IG; Brown BR
Life Sci; 1978 Dec; 23(25):2447-62. PubMed ID: 32456
[No Abstract] [Full Text] [Related]
4. Metabolism of synthane: comparison with in vivo and in vitro defluorination of other halogenated hydrocarbon anaesthetics.
Mazze RI; Beppu WJ; Hitt BA
Br J Anaesth; 1979 Sep; 51(9):839-44. PubMed ID: 508489
[TBL] [Abstract][Full Text] [Related]
5. Halogenated hydrocarbon environmental pollution: the special case of halogenated anesthetics.
Marier JR
Environ Res; 1982 Jun; 28(1):212-39. PubMed ID: 6125384
[No Abstract] [Full Text] [Related]
6. [Metabolism and toxicity of anesthetics].
Bito H
Masui; 1999; 48 Suppl():S172-9. PubMed ID: 10785976
[No Abstract] [Full Text] [Related]
7. Effect of streptozotocin-induced diabetes in the rat on the metabolism of fluorinated volatile anesthetics.
Pantuck EJ; Pantuck CB; Conney AH
Anesthesiology; 1987 Jan; 66(1):24-8. PubMed ID: 3541691
[TBL] [Abstract][Full Text] [Related]
8. [The biotransformation of inhalation anaesthetics and its relevance to clinical side effects (author's transl)].
Rietbrock I
Anaesthesist; 1975 Sep; 24(9):381-91. PubMed ID: 1103649
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of the biotransformation of inhalation anesthetics.
Brown BR
South Med J; 1976 May; 69(5):554-6. PubMed ID: 5782
[TBL] [Abstract][Full Text] [Related]
10. [Biotransformation of halogen anesthetics and liver toxicity].
Duvaldestin P; Desmonts JM
Ann Anesthesiol Fr; 1976; 17(3):315-20. PubMed ID: 984518
[TBL] [Abstract][Full Text] [Related]
11. Toxicology of inhalation anesthetics and metabolites.
Van Stee EW
Annu Rev Pharmacol Toxicol; 1976; 16():67-79. PubMed ID: 7186
[No Abstract] [Full Text] [Related]
12. Metabolism of anesthetic agents: toxic implications.
Van Dyke RA
Acta Anaesthesiol Scand Suppl; 1982; 75():7-9. PubMed ID: 6958162
[No Abstract] [Full Text] [Related]
13. Effects of thyroid dysfunction on the metabolism of halothane, enflurane and methoxyflurane in rats.
Siegers CP; Mackenroth T; Wächter S; Younes M
Pharmacology; 1981; 22(1):41-6. PubMed ID: 7220596
[TBL] [Abstract][Full Text] [Related]
14. The extent of metabolism of inhaled anesthetics in humans.
Carpenter RL; Eger EI; Johnson BH; Unadkat JD; Sheiner LB
Anesthesiology; 1986 Aug; 65(2):201-5. PubMed ID: 3740510
[TBL] [Abstract][Full Text] [Related]
15. Enflurane, isoflurane, and methoxyflurane metabolism in rat hepatic microsomes from ethanol-treated animals.
Van Dyke RA
Anesthesiology; 1983 Mar; 58(3):221-4. PubMed ID: 6829956
[TBL] [Abstract][Full Text] [Related]
16. Uptake of volatile anaesthetics in children.
Gallagher TM; Black GW
Anaesthesia; 1985 Nov; 40(11):1073-7. PubMed ID: 4073423
[TBL] [Abstract][Full Text] [Related]
17. [Role of biotransformation in the toxicity of volatil anesthetics].
Dauchot PJ; Cascorbi HF
Anesth Analg (Paris); 1976; 33(5):723-5. PubMed ID: 1008280
[No Abstract] [Full Text] [Related]
18. Extrahepatic biotransformation of halothane and enflurane.
Blitt CD; Gandolfi AJ; Soltis JJ; Brown BR
Anesth Analg; 1981 Mar; 60(3):129-32. PubMed ID: 7193988
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and biotransformation alterations in obesity.
Vaughan RW
Contemp Anesth Pract; 1982; 5():55-70. PubMed ID: 7053318
[No Abstract] [Full Text] [Related]
20. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
Kharasch ED; Thummel KE
Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
